The most useful measurements in medicine are those which relate directly to function, or to morbidity or mortality. Variates which have no known relationship to function or to disease may be of interest to the physiologist, but their measurement would seem to add little to clinical medicine. The measurement of circulating hvmoglobin is only reasonable, therefore, if it is shown that low levels indicate malfunction or ill health. The detection of levels which differ from 'normal' values, however these are defined, is only of importance if there is valid evidence that such a difference is indicative of increased morbidity. It is the purpose of this paper to examine circulating hemoglobin level as an index of morbidity. The only aspects of anmmia which will be considered are the associations between circulating haemoglobin level, and symptoms and cardiorespiratory function, and the effects of iron therapy.
In a survey of a total community, about 1,000 adult women were seen, and this represented about 93 % of the total eligible population in the area. In these, the severities of a variety of symptoms were assessed by questionnaire. This was a self-administered form of the method Dr J G Ingham has described (p 492). The results gave no evidence to support the belief that low levels of circulating hemoglobin are associated with the more severe grades of any symptom (Elwood et al. 1969 ).
The effect on symptoms of a change in hxemoglobin level following iron therapy was then studied. In the survey which has been described about 100 women had hiemoglobin levels below 12 g/100 ml blood. These were given, at random, either oral iron in conventional doses or identical placebo tablets which contained no iron. Although this led to a rise in those given iron which exceeded the change in those given placebo by over 1-6 g Hb/100 ml blood, there were no significant differences in the changes in the severities of the various symptoms in the two groups (Elwood etal. 1969 ).
An extension of the concept of iron deficiency as a cause of symptoms has recently been advanced. This is, that even in the absence of anemia, iron deficiency can exist and cause symptoms which respond to ironin particular, fatigue (Beutler & Larsh 1960) . Although there is some physiological basis for this, the evidence from clinical trials is conflicting (Dagg et al. 1968 , Elwood et al. 1969 . In any case a concept such as this, in the absence of unequivocal evidence, seems to be not without dangers. If symptoms, and in particular fatigue, are believed to occur because of iron deficiency in the absence of anaemia, then the measurement of circulating hemoglobin could be considered unnecessary before iron is prescribed for a patient who complains of fatigue, or possibly other symptoms. Furthermore, such a concept may lead to the diagnosis of iron deficiency being used as a 'scapegoat' in patients whose symptoms should be investigated further.
Anemia is believed to have a harmful effect on cardiorespiratory function. To examine this a population sample of almost 3,000 women were seen and cardiorespiratory function was assessed in the 1 % of subjects with the lowest levels of circulating hmemoglobin (all below 9 5 g/100 ml blood).
The results were compared with those of a further random sample of 80 women with normal levels of circulating hemoglobin. There was no evidence in these results of any clinically important difference in 'transfer factor', 'exercise ventilation' or 'exercise cardiac frequency'. Furthermore, although iron therapy had a very marked effect on circulating hemoglobin and on total body hemoglobin there was no evidence that it had any beneficial effect on cardiorespiratory function.
The original objective in all this work was for a meaningful interpretation of heamoglobin level as an index of morbidity. It was felt that if a level of circulating haemoglobin could be defined below which symptoms or effects occurred which respond to iron, then this would be a useful and meaningful diagnostic criterion of 'anmmia' and would lead to the definition of valid and reasonable 'normal' values of blood hemoglobin concentration. In fact no evidence of any harmful effect in terms of symptoms or cardiorespiratory function has yet been found.
This work is not presented as conclusive or exhaustive. The studies described have been small and have not considered all aspects of morbidity of possible relevance to circulating hemoglobin. However, they do indicate that, although hmmoglobin level is one of the easiest and most frequently made measurements in clinical practice, its interpretation as an index of morbidity is open to considerable doubt.
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